These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 103560)

  • 1. Antibodies reacting with ribosomal ribonucleoprotein in connective tissue diseases.
    Miyachi K; Tan EM
    Arthritis Rheum; 1979 Jan; 22(1):87-93. PubMed ID: 103560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial estimation of anti-RNP antibody titers in systemic lupus erythematosus, mixed connective tissue disease and rheumatoid arthritis.
    Nishikai M; Okano Y; Mukohda Y; Sato A; Ito M
    J Clin Lab Immunol; 1984 Jan; 13(1):15-9. PubMed ID: 6609234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of clinical disease associated with antibodies to nuclear ribonucleoprotein.
    Maddison PJ; Mogavero H; Reichlin M
    J Rheumatol; 1978; 5(4):407-11. PubMed ID: 310884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-ribosomal ribonucleoprotein autoantibodies in systemic lupus erythematosus.
    Meroni PL; de Bartolo G; Barcellini W; Riboldi PS; Basile R; Betterle C; Zanussi C
    J Clin Immunol; 1984 Jan; 4(1):45-54. PubMed ID: 6421870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to heterogeneous nuclear ribonucleoproteins in sera from patients with rheumatic autoimmune diseases.
    Zouali M; Eyquem A
    J Clin Immunol; 1984 May; 4(3):209-19. PubMed ID: 6610689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to ribosomal ribonucleoprotein. Prevalence in systemic rheumatic diseases and partial characterization of the antigen.
    Cortés JJ; Mendoza F; Reyes PA
    J Rheumatol; 1987 Aug; 14(4):727-31. PubMed ID: 3118019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical characteristics of patients with nuclear antiribonucleoprotein antibodies. Evidence of circulating immunocomplexes in mixed connective tissue disease].
    Rodríguez-Valverde V; Orte Martínez J; Sampedro Alvarez J; Peña Sagredo JL; Sánchez Andrada S
    Med Clin (Barc); 1982 Jun; 79(1):9-15. PubMed ID: 7121111
    [No Abstract]   [Full Text] [Related]  

  • 8. Autoimmune response to the spliceosome. An immunologic link between rheumatoid arthritis, mixed connective tissue disease, and systemic lupus erythematosus.
    Hassfeld W; Steiner G; Studnicka-Benke A; Skriner K; Graninger W; Fischer I; Smolen JS
    Arthritis Rheum; 1995 Jun; 38(6):777-85. PubMed ID: 7779120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of specific antibodies to extractable nuclear antigens by passive immunodiffusion.
    Kozin F; Fowler M
    Am J Clin Pathol; 1979 Apr; 71(4):437-40. PubMed ID: 108995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of an integrated ELISA system for the detection of 6 autoantibodies (ssDNA, dsDNA, Sm, RNP/Sm, SSA, and SSB).
    Froelich CJ; Wallman J; Skosey JL; Teodorescu M
    J Rheumatol; 1990 Feb; 17(2):192-200. PubMed ID: 2108246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free serum ribonucleoprotein in mixed connective tissue disease and other connective tissue diseases.
    Fishbein E; Ramos-Niembro F; Alarcon-Segovia D
    J Rheumatol; 1978; 5(4):384-90. PubMed ID: 310882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies from patients with mixed connective tissue disease react with heterogeneous nuclear ribonucleoprotein or ribonucleic acid (hnRNP/RNA) of the nuclear matrix.
    Fritzler MJ; Ali R; Tan EM
    J Immunol; 1984 Mar; 132(3):1216-22. PubMed ID: 6198384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The correlation of antibodies to nuclear ribonucleoprotein (RNP) and nuclear acidic protein (Sm) with nephritis in patients with systemic lupus erythematosus (SLE).
    Kurata N; Hara I; Kinashi M; Akita H; Ofuji T
    Contrib Nephrol; 1978; 9():17-24. PubMed ID: 668385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of IgG subclasses of Anti-Sm and U1 ribonucleoprotein antibodies in patients with systemic lupus erythematosus and mixed connective tissue disease.
    Tokano Y; Yasuma M; Harada S; Takasaki Y; Hashimoto H; Okumura K; Hirose S
    J Clin Immunol; 1991 Nov; 11(6):317-25. PubMed ID: 1837028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of patients with serum antibodies to extractable nuclear antigens.
    Leibfarth JH; Persellin RH
    Arthritis Rheum; 1976; 19(5):851-6. PubMed ID: 786296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features of patients with antibodies directed against proliferating cell nuclear antigen.
    Fritzler MJ; McCarty GA; Ryan JP; Kinsella TD
    Arthritis Rheum; 1983 Feb; 26(2):140-5. PubMed ID: 6600614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiles of antinuclear antibodies in systemic rheumatic diseases.
    Notman DD; Kurata N; Tan EM
    Ann Intern Med; 1975 Oct; 83(4):464-9. PubMed ID: 1080976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatology and diagnosis in connective tissue disease. Antibodies to extractable ribonucleoprotein in 123 patients reacting with cell nuclei in the immunofluorescence test.
    Jonsson J
    Scand J Rheumatol; 1976; 5(3):177-83. PubMed ID: 790556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of screening for antibody to ribonucleoprotein.
    Small P; Barrett D; Champlin E
    Ann Allergy; 1982 Sep; 49(3):152-5. PubMed ID: 6981365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of U1-RNP immune complexes in mixed connective tissue disease and systemic lupus erythematosus.
    Negoro N; Kanayama Y; Takeda T; Amatsu K; Koda S; Inoue Y; Kim T; Okamura M; Inoue T
    Rheumatol Int; 1987; 7(1):7-11. PubMed ID: 2954202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.